AVGO vs CALX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
CALX exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a negligible Debt/Equity ratio of 0.02, indicating a very stable balance sheet. However, there is a severe disconnect between the current price ($43.38) and deterministic value metrics, with the Graham Number at $11.88 and Intrinsic Value at $3.43. While the Forward P/E of 17.33 suggests significant earnings growth potential, the stock is currently plagued by heavy insider selling ($54.23M) and a sharp bearish technical trend. The overall outlook is neutral as the high-quality financial health is offset by extreme valuation premiums and negative sentiment.
Compare Another Pair
Related Comparisons
AVGO vs CALX: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and Calix, Inc. (CALX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.